Prevalence of Cardiovascular Diseases to Bolster the Demand for Veno-Arterial Systems

ECMO is the abbreviation of Extracorporeal membrane oxygenation. It is a cardio-pulmonary life-support system mainly used for oxygenating blood outside the heart. This device is a heart-lung machine specially used in bypass surgeries.  The Veno-Arterial ECMO is specially used for draining the blood from the vein and then circulating the blood outside the body, the carbon dioxide from the blood is removed and adds oxygen introduced and then blood then reintroduced into the artery. This Veno-Arterial system enables the hearts and lungs to rest and assist in recovery.

The Veno-Arterial EMSO is getting demand from multi-speciality hospitals and cardiac surgery hospitals. The rising adoption of life support systems to increase the survival rate are majorly driving the market growth. The growing need for Veno-Arterial ECMO systems during and after heart surgeries is propelling the growth of the Veno-Arterial ECMO systems market. The rise in the number of patients suffering from cardiovascular diseases and the upsurge in the geriatric population across the globe are fuelling the market growth.

Veno-Arterial Systems Market Dynamics

The {global Veno-Arterial systems market} was valued at USD 271.44 Million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% between 2021 to 2028. The Veno-Arterial ECMO systems market was slightly impacted during the initial days of the COVID-19 outbreak owing to the delay in non-emergency heart surgeries. The hospitality facilities were focused on treating the covid-19 patients leading to restraining the Veno-Arterial systems market. The market then recovered rapidly owing to the growing demand for ECMO procedures.

The Veno-Arterial ECMO machines are primarily classified on the basis of the type of product and the application. The Veno-Arterial ECMO machines are usually of two types including portable type and fixed type of devices.  And based on application and end-users the machines are required by the paediatric, neonatal, and adult patients.

The leading manufacturers of the Veno-venous ECMO systems are Xenios AG, Medtronic, Maquet Holding, ALung Technologies and Sorin Group. The presence of well-established vendors is making the Veno-venous ECMO systems is highly competitive.

The presence of a large number of ECMO centres in the U.S. is making the North American region the regionally dominant player. Additionally, the rising incidence of lung cancer and favourable reimbursement scenario are fuelling the North-America growth. The rise in adoption of the Veno-Arterial ECMO systems by the countries like Japan, China and India are estimated to provide lucrative growth opportunities for the growth of the Veno-Arterial ECMO systems market.